Anticapsular and Antifungal Activity of α-Cyperone

Area of Science:

• Mycology
• Pharmacology
• Natural Product Chemistry

Background:

• Fungal infections cause 1.5 million deaths annually, with rising threats from drug-resistant species like Candida auris.
• Opportunistic fungal infections are increasing in immunosuppressed populations.
• Existing antifungal drugs are limited and often ineffective against fungal capsules and spores.

Purpose of the Study:

• To identify novel antifungal agents from medicinal plants.
• To investigate the antifungal activity of compounds from Cyperus rotundus.
• To explore the potential of α-Cyperone in combination therapy and against fungal virulence factors.

Main Methods:

• Screening of medicinal plant extracts for antifungal activity.
• Isolation and identification of active compounds, specifically α-Cyperone.
• Testing α-Cyperone's fungicidal activity against Candida species.
• Evaluating the synergistic effect of α-Cyperone with fluconazole.
• Assessing α-Cyperone's impact on Cryptococcus neoformans capsule synthesis.

Main Results:

• An active fraction from Cyperus rotundus rhizome containing α-Cyperone demonstrated fungicidal activity against Candida species.
• α-Cyperone showed an 8-fold reduction in minimal inhibitory concentration when combined with fluconazole, indicating synergy.
• α-Cyperone inhibited capsule synthesis in Cryptococcus neoformans.

Conclusions:

• α-Cyperone is a promising candidate for novel antifungal drug development.
• Combination therapy with α-Cyperone and fluconazole could enhance treatment efficacy.
• α-Cyperone's ability to disrupt fungal capsules suggests potential against virulent fungal pathogens.